Io Therapeutics (United States)
ORCID: 0009-0005-2508-7282Also affiliated with Stanford University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia”.
Jose Mario Bello Pineda, Won Jun Kim, Sisi Chen, Jessie Bourcier, Maximilian Stahl +22 more